Table 7.

Variables with significant changes in divided patients according to United Kingdom and Michigan screening.

Group	UK score				Michigan score
	0–4		5–9		0–2		2.5–8
ANGIPARSTM	variable	df	variable	df	Variable	df	variable	df
	DL of Median s.	0.33	DL of Ulnar m.	−0.30	DL of Median s.	0.36	DL of Ulnar s.	−0.27
	AM of Ulnar m.	0.97	AM of Ulnar m	1.11	NCV of Median s.	−2.83	DL of Ulnar m.4	−0.21
	DL of Tibial1	−0.76	AM of Median s.3	−2.40	DL of Ulnar m.	−0.19	Michigan screening	−1.71
			Michigan score	−1.31	AM of Ulnar m	0.93
					NCV of Ulnar m.	4.28
					Michigan score	−1.11
Placebo	DL of Sural	0.31	DL of Sural	0.35	DL of Sural	0.38	AM of Sural	−6.27
	NCV of Tibial	5.14	NCV of Sural	−5.50	DL of Median s.	0.40	AM of proneal	−0.50
	NCV of Ulnar m2	5.00	NCV of Median s.	−3.44	NCV of Median s.	−3.85	NCV of Ulnar m.	5.00
			AM of Proneal	−0.34	NCVof Median m	−5.46	Michigan screening	0.91
			DL of Median m.	−0.27	NCV of Tibial	1.75	−5.46
			VAS	−0.19

1-Pvalue=0.055; 2- P value=0.053; 3- P value=0.052; 4- P value=0.057; DL: Distal Latency (millisecond); AM: Amplitude (microvolt); NCV: Nerve Conduction Velocity (m/s); m: motor; s: sensory; df: difference between variable mean at the endpoint versus baseline; VAS: visual analog scale.